WHICH INDICATORS CAN PUBLIC HEALTH AUTHORITIES USE TO MONITOR PRESCRIPTION DRUG ABUSE AND EVALUATE THE IMPACT OF REGULATORY MEASURES? CONTROLLING HIGH DOSAGE BUPRENORPHINE ABUSE
Shranjeno v:
PAULY, V., ET AL., WHICH INDICATORS CAN PUBLIC HEALTH AUTHORITIES USE TO MONITOR PRESCRIPTION DRUG ABUSE AND EVALUATE THE IMPACT OF REGULATORY MEASURES? CONTROLLING HIGH DOSAGE BUPRENORPHINE ABUSE. DRUG AND ALCOHOL DEPENDENCE, Vol. 113, no. 1 (2011), p. 29-36.
Ref.
176587
Lokacija:
SIIS R.854 Archivo
Palabras clave:
Buprenorfina, Drogodependencias, Fármacos, Programas de mantenimiento, Recetas médicas, Tratamiento médico, Francia
Buprenorfina, Drogodependencias, Fármacos, Programas de mantenimiento, Recetas médicas, Tratamiento médico, Francia
Podobne knjige/članki: WHICH INDICATORS CAN PUBLIC HEALTH AUTHORITIES USE TO MONITOR PRESCRIPTION DRUG ABUSE AND EVALUATE THE IMPACT OF REGULATORY MEASURES? CONTROLLING HIGH DOSAGE BUPRENORPHINE ABUSE
- INDICATIONS, REGLES ET TECHNIQUES DE PRESCRIPTION DE LA BUPRENORPHINE
- BUPRENORPHINE HAUT DOSAGE
- COMPARISON OF METHADONE AND HIGH DOSAGE BUPRENORPHINE USERS IN FRENCH CARE CENTRES
- Evaluating the implementation of a prescription only regulatory model for nicotine vaping products: A qualitative study on the experiences and views of healthcare professionals
- Systematic assessment of non-medical use of prescription drugs using doctor-shopping indicators: a nation-wide, repeated cross-sectional study
- A European Community Pharmacy-Based Survey to investigate patterns of prescription fraud through identification of falsified prescriptions